Suppr超能文献

利用蛋白质-蛋白质相互作用预测指导竞争性结合测定:HER2-亲和体应用案例

Guiding Competitive Binding Assays Using Protein-Protein Interaction Prediction: The HER2-Affitin Use Case.

作者信息

Ranaudo Anna, Cosentino Ugo, Greco Claudio, Moro Giorgio, Maiocchi Alessandro, Moroni Elisabetta

机构信息

Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy.

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, Italy.

出版信息

ACS Omega. 2024 Dec 5;9(50):49522-49529. doi: 10.1021/acsomega.4c07317. eCollection 2024 Dec 17.

Abstract

Affitins are a class of small artificial proteins, designed as alternatives to antibodies for therapeutic, diagnostic, and biotechnological applications. Recent patents by Bracco Imaging S.p.A have demonstrated the potential of two engineered affitins for designing imaging probes to detect and monitor human epidermal growth-factor receptor 2 (HER2) levels . Targeting HER2 is critical, as its overexpression is linked to poor prognosis of several cancer diseases, making it a key marker for treatment strategies and diagnostic tools. Interestingly, these affitins do not compete with the commonly used monoclonal antibodies trastuzumab and pertuzumab for HER2 binding sites, allowing their concurrent use and making them suitable for imaging or diagnostic purposes. Since these two affitins compete for the same yet unidentified binding site on HER2, structural insights into these interactions are essential for facilitating the design and development of more effective diagnostic tools and treatments. In this study, we used protein-protein docking and molecular dynamics simulations to model the binding of these affitins to HER2. The stability of the predicted complexes was quantified by using the DockQ parameter, a widely used metric for evaluating protein-protein docking predictions. The docking poses were then compared with HER2 sites likely to interact with a protein partner, as predicted by the matrix of local coupling energies method. The combination of these two computational methods allowed for the identification of the most likely docking poses. Comparative analysis with HER2-protein complexes from the Protein Data Bank suggests that both affitins may bind HER2 at the same epitopes as an antibody fragment and an affibody. These findings indicate that targeted competitive binding assays could efficiently reduce the experimental efforts to map the HER2-affitin interactions. The computational approach proposed in this study not only provides insights into this specific case but also establishes a robust framework applicable for facilitating the structural modeling and interaction prediction of other affitin-protein systems.

摘要

亲合素是一类小型人工蛋白质,被设计作为抗体的替代品,用于治疗、诊断和生物技术应用。百时美施贵宝公司最近的专利证明了两种工程亲合素在设计成像探针以检测和监测人表皮生长因子受体2(HER2)水平方面的潜力。靶向HER2至关重要,因为其过表达与几种癌症疾病的不良预后相关,使其成为治疗策略和诊断工具的关键标志物。有趣的是,这些亲合素不会与常用的单克隆抗体曲妥珠单抗和帕妥珠单抗竞争HER2结合位点,从而允许它们同时使用,并使其适用于成像或诊断目的。由于这两种亲合素竞争HER2上相同但尚未确定的结合位点,因此对这些相互作用的结构洞察对于促进更有效的诊断工具和治疗方法的设计和开发至关重要。在本研究中,我们使用蛋白质-蛋白质对接和分子动力学模拟来模拟这些亲合素与HER2的结合。通过使用DockQ参数对预测复合物的稳定性进行量化,DockQ参数是一种广泛用于评估蛋白质-蛋白质对接预测的指标。然后将对接姿势与通过局部耦合能量矩阵方法预测的可能与蛋白质伴侣相互作用的HER2位点进行比较。这两种计算方法的结合使得能够识别最可能的对接姿势。与蛋白质数据库中HER2-蛋白质复合物的比较分析表明,两种亲合素可能在与抗体片段和亲和体相同的表位结合HER2。这些发现表明,靶向竞争性结合试验可以有效地减少绘制HER2-亲合素相互作用图谱的实验工作量。本研究中提出的计算方法不仅为这一特定案例提供了见解,还建立了一个稳健的框架,适用于促进其他亲合素-蛋白质系统的结构建模和相互作用预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ab/11656212/75c813f61887/ao4c07317_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验